De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
Clinical trial NCT05255302 · RECRUITING
Trial details
- NCT number
- NCT05255302
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2025-05-01
- Enrollment
- 1360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.